United States · FDA National Drug Code directory
CARBIDOPA AND LEVODOPA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53401-020_5644f547-ed81-4b19-e063-6394a90a014b
- Product NDC
- 53401-020
- Form
- TABLET
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260119
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 25 mg/1
- LEVODOPA — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (53401-020-60) · 53401-020-60
- 180 TABLET in 1 BOTTLE (53401-020-80) · 53401-020-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →